Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kairos Pharma | KAPA | Nov 21, 2024 | 1.50 | 0.00 |
Kairous Acquisition | KACL | Nov 21, 2024 | 12.46 | 0.00 |
Kaiser Aluminium | KALU | Nov 21, 2024 | 81.18 | +1.17 |
Kaival Brands Innovations Group | KAVL | Nov 21, 2024 | 0.80 | -3.10 |
Kaixin Holdings | KXIN | Nov 21, 2024 | 2.33 | -7.54 |
Kala Bio | KALA | Nov 21, 2024 | 6.55 | +1.87 |
Kaltura | KLTR | Nov 21, 2024 | 2.20 | +7.32 |
KalVista Pharmaceuticals | KALV | Nov 21, 2024 | 9.32 | +4.07 |
Kamada | KMDA | Nov 21, 2024 | 5.85 | +0.52 |
Kandi Technologies Group | KNDI | Nov 21, 2024 | 1.15 | +4.55 |
Kanzhun ADR | BZ | Nov 21, 2024 | 12.92 | -3.87 |
Karat Packaging | KRT | Nov 21, 2024 | 29.60 | +3.68 |
Karooooo | KARO | Nov 21, 2024 | 40.51 | +1.81 |
Kartoon Studios | TOON | Nov 21, 2024 | 0.77 | +3.69 |
Karyopharm Therapeutics | KPTI | Nov 21, 2024 | 0.78 | +0.34 |
Katapult | KPLT | Nov 21, 2024 | 6.26 | +4.33 |
Kayne Anderson BDC | KBDC | Nov 21, 2024 | 16.35 | +1.24 |
Kayne Anderson Energy Infrastructure Fund | KYN | Nov 21, 2024 | 13.37 | +1.60 |
Kazia Therapeutics ADR | KZIA | Nov 21, 2024 | 5.53 | -1.43 |
KB Financial Group ADR | KB | Nov 21, 2024 | 69.13 | +1.78 |
KB Home | KBH | Nov 21, 2024 | 77.79 | -0.23 |
KBR | KBR | Nov 21, 2024 | 60.23 | +3.70 |
KBW Bank Powershares | KBWB | Nov 21, 2024 | 69.54 | +1.58 |
KBW High Div Yield Financial Powershares | KBWD | Nov 21, 2024 | 15.20 | +0.80 |
KBW Prem Yield Equity REIT Powershares | KBWY | Nov 21, 2024 | 19.63 | +1.08 |
KBW Prop & Casuality Insur Powershares | KBWP | Nov 21, 2024 | 123.33 | +1.72 |
KBW Regional Banking Powershares | KBWR | Nov 21, 2024 | 65.53 | +1.64 |
KE Holdings | BEKE | Nov 21, 2024 | 19.98 | -1.24 |
Kearny Financial | KRNY | Nov 21, 2024 | 8.19 | +1.49 |
Keen Vision Acquisition | KVAC | Nov 21, 2024 | 10.87 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.